Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Ischemic Heart Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 229 articles:
HTML format



Single Articles


    May 2020
  1. TSIMIKAS S, Karwatowska-Prokopczuk E, Xia S
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Reply.
    N Engl J Med. 2020;382:e65.
    PubMed    


  2. FERRO CJ, Sarafidis P, Ortiz A
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    


  3. ANDREOTTI F, Maggioni AP
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    


  4. ALKHALIL M
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    


  5. SOLOMON MD, McNulty EJ, Rana JS, Leong TK, et al
    The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.
    N Engl J Med. 2020 May 19. doi: 10.1056/NEJMc2015630.
    PubMed    


  6. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2007621.
    PubMed     Abstract available


    April 2020
  7. TARDIF JC, L'Allier PL, Guertin MC
    Low-Dose Colchicine after Myocardial Infarction. Reply.
    N Engl J Med. 2020;382:1668.
    PubMed    


  8. CHIARITO M, Condorelli G, Stefanini GG
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1667-1668.
    PubMed    


  9. REINDL M, Metzler B, Reinstadler SJ
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1667.
    PubMed    


  10. FURER V, Elkayam O, Caspi D
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1666-1667.
    PubMed    


  11. KITTLESON MM
    The Invisible Hand - Medical Care during the Pandemic.
    N Engl J Med. 2020;382:1586-1587.
    PubMed    


  12. SPERTUS JA, Jones PG, Maron DJ, Mark DB, et al
    Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
    N Engl J Med. 2020;382:1619-1628.
    PubMed     Abstract available


  13. MEHTA SR, Wood DA, Cairns JA
    Complete Revascularization with Multivessel PCI for Myocardial Infarction. Reply.
    N Engl J Med. 2020;382:1571-1572.
    PubMed    


  14. DOENST T, Boning A, Thiele H
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1571.
    PubMed    


  15. FERREIRA RM, Salis LHA, de Souza E Silva NA
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1570.
    PubMed    


  16. BURGESS SN, Juergens CP, French JK
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569-1570.
    PubMed    


  17. DESCHNER M, Glanz A
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569.
    PubMed    


  18. AUER J, Berent R, Gurtner F
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569.
    PubMed    


  19. BOGATY P, Brophy JM
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1568.
    PubMed    


  20. RAY KK, Wright RS, Kallend D, Koenig W, et al
    Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
    N Engl J Med. 2020;382:1507-1519.
    PubMed     Abstract available


    March 2020
  21. BANGALORE S, Maron DJ, O'Brien SM, Fleg JL, et al
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915925.
    PubMed     Abstract available


  22. MARON DJ, Hochman JS, Reynolds HR, Bangalore S, et al
    Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915922.
    PubMed     Abstract available


  23. SPERTUS JA, Jones PG, Maron DJ, O'Brien SM, et al
    Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1916370.
    PubMed     Abstract available


  24. ANTMAN EM, Braunwald E
    Managing Stable Ischemic Heart Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMe2000239.
    PubMed    


  25. WINDECKER S, Latib A, Kedhi E, Kirtane AJ, et al
    Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
    N Engl J Med. 2020;382:1208-1218.
    PubMed     Abstract available



  26. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    N Engl J Med. 2020;382:1078.
    PubMed    


  27. BOHOSSIAN HB, Lopes EW, Roller LA, Ananthakrishnan AN, et al
    Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools.
    N Engl J Med. 2020;382:1042-1052.
    PubMed    


    February 2020
  28. OLENSKI AR, Zimerman A, Coussens S, Jena AB, et al
    Behavioral Heuristics in Coronary-Artery Bypass Graft Surgery.
    N Engl J Med. 2020;382:778-779.
    PubMed    


    January 2020
  29. SCHUPKE S, Kastrati A
    Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply.
    N Engl J Med. 2020;382:487.
    PubMed    


  30. SHARMA S, Lardizabal J, Sharma R
    Ticagrelor or Prasugrel in Acute Coronary Syndromes.
    N Engl J Med. 2020;382:487.
    PubMed    


  31. CARBONELL-PRAT B, Flores-Umanzor E, Brugaletta S
    Ticagrelor or Prasugrel in Acute Coronary Syndromes.
    N Engl J Med. 2020;382:486.
    PubMed    


  32. WANG TJ, Munoz D, Blot WJ
    Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply.
    N Engl J Med. 2020;382:95.
    PubMed    


  33. BILAL U, Cainzos-Achirica M
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2020;382:94-95.
    PubMed    


  34. BRUGTS JJ
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2020;382:94.
    PubMed    


  35. TSIMIKAS S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif JC, et al
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020 Jan 1. doi: 10.1056/NEJMoa1905239.
    PubMed     Abstract available


    December 2019
  36. NEUMANN JT, Twerenbold R, Blankenberg S
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. Reply.
    N Engl J Med. 2019;381:2483.
    PubMed    


  37. AKSOY A, Agirbasli M
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;381:2482-2483.
    PubMed    


  38. LAU CS, Aw TC
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;381:2482.
    PubMed    


  39. YASUDA S, Ogawa H
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Reply.
    N Engl J Med. 2019;381:2481.
    PubMed    


  40. GREMMEL T
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2480-2481.
    PubMed    


  41. PATTI G, De Caterina R
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2480.
    PubMed    


  42. MARQUIS-GRAVEL G, Roe MT
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2479-2480.
    PubMed    


  43. PANZA JA, Velazquez EJ, Bonow RO
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. Reply.
    N Engl J Med. 2019;381:2374.
    PubMed    


  44. SHARMA S, Sharma R, Lardizabal J
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:2373.
    PubMed    


  45. NAPP LC, Bengel FM, Bauersachs J
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:2373.
    PubMed    


  46. NAGEL E, Berry C
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. Reply.
    N Engl J Med. 2019;381:2277-2278.
    PubMed    


  47. TEBALDI M, Biscaglia S, Campo G
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2277.
    PubMed    


  48. DESCHNER M, Glanz A
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2276-2277.
    PubMed    


  49. O'ROURKE MF, Adji A
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2276.
    PubMed    


    November 2019
  50. HUSAIN M, Donsmark M, Bain SC
    Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2019;381:2076-2077.
    PubMed    


  51. ZWECK E, Westenfeld R, Szendroedi J
    Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;381:2075-2076.
    PubMed    


  52. MEHRAN R, Baber U, Sharma SK, Cohen DJ, et al
    Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
    N Engl J Med. 2019;381:2032-2042.
    PubMed     Abstract available


  53. TARDIF JC, Kouz S, Waters DD, Bertrand OF, et al
    Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1912388.
    PubMed     Abstract available


  54. NEWBY LK
    Inflammation as a Treatment Target after Acute Myocardial Infarction.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMe1914378.
    PubMed    


    October 2019

  55. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    N Engl J Med. 2019;381:1789.
    PubMed    


  56. BRIOSA E GALA A, Rawlins J
    Posterior-Wall Myocardial Infarction.
    N Engl J Med. 2019;381:e32.
    PubMed    


  57. FLINT AC, Conell C, Bhatt DL
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes. Reply.
    N Engl J Med. 2019;381:1692-1693.
    PubMed    


  58. VERDECCHIA P, Angeli F, Reboldi G
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1691-1692.
    PubMed    


  59. QUINN S, McEvoy JW
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1690-1691.
    PubMed    


  60. KOSTIS WJ, Kostis JB, Moreyra AE
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1690.
    PubMed    


  61. BERNSTEIN SN, Cudemus-Deseda GA, Ortiz VE, Goodman A, et al
    Case 33-2019: A 35-Year-Old Woman with Cardiopulmonary Arrest during Cesarean Section.
    N Engl J Med. 2019;381:1664-1673.
    PubMed    


  62. CLAASSENS DMF, Vos GJA, Bergmeijer TO, Hermanides RS, et al
    A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
    N Engl J Med. 2019;381:1621-1631.
    PubMed     Abstract available


  63. JNEID H
    Ticagrelor or Prasugrel in Acute Coronary Syndromes - The Winner Takes It All?
    N Engl J Med. 2019;381:1582-1585.
    PubMed    


  64. MICHOS ED, McEvoy JW, Blumenthal RS
    Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2019;381:1557-1567.
    PubMed    


  65. KOBER L, Engstrom T
    A More COMPLETE Picture of Revascularization in STEMI.
    N Engl J Med. 2019;381:1472-1474.
    PubMed    


    September 2019
  66. STONE GW, Kappetein AP, Sabik JF, Pocock SJ, et al
    Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1909406.
    PubMed     Abstract available


  67. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2019;381:1114-1123.
    PubMed     Abstract available


  68. YASUDA S, Kaikita K, Akao M, Ako J, et al
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMoa1904143.
    PubMed     Abstract available


  69. BECKER RC
    Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMe1910560.
    PubMed    


  70. STEG PG, Bhatt DL, Simon T, Fox K, et al
    Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908077.
    PubMed     Abstract available


  71. BATES ER
    Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMe1910813.
    PubMed    


  72. MEHTA SR, Wood DA, Storey RF, Mehran R, et al
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1907775.
    PubMed     Abstract available


  73. SCHUPKE S, Neumann FJ, Menichelli M, Mayer K, et al
    Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908973.
    PubMed     Abstract available


    August 2019
  74. PANZA JA, Ellis AM, Al-Khalidi HR, Holly TA, et al
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:739-748.
    PubMed     Abstract available


    July 2019
  75. HARDIN CC, Malhotra R, Petranovic M, Klassen S, et al
    Case 23-2019: A 52-Year-Old Man with Fever, Cough, and Hypoxemia.
    N Engl J Med. 2019;381:359-369.
    PubMed    


  76. FLINT AC, Conell C, Ren X, Banki NM, et al
    Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.
    N Engl J Med. 2019;381:243-251.
    PubMed     Abstract available


  77. LEMKES JS, Janssens GN, van Royen N
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. Reply.
    N Engl J Med. 2019;381:189-190.
    PubMed    


  78. DE SILVA K, Perera D
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:189.
    PubMed    


  79. KIM YJ, Kim WY
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:189.
    PubMed    


  80. WALDMANN V, Bonnet G, Spaulding C
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:188-189.
    PubMed    


  81. DEGRELL P, Varenne O
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:188.
    PubMed    


    June 2019
  82. NEUMANN JT, Twerenbold R, Ojeda F, Sorensen NA, et al
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;380:2529-2540.
    PubMed     Abstract available


  83. NAGEL E, Greenwood JP, McCann GP, Bettencourt N, et al
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;380:2418-2428.
    PubMed     Abstract available


  84. HUSAIN M, Birkenfeld AL, Donsmark M, Dungan K, et al
    Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2019 Jun 11. doi: 10.1056/NEJMoa1901118.
    PubMed     Abstract available


  85. RIDKER PM
    Methotrexate for Prevention of Cardiovascular Events. Reply.
    N Engl J Med. 2019;380:2277.
    PubMed    


  86. HUANG Y, Chan AW, Shear NH
    Methotrexate for Prevention of Cardiovascular Events.
    N Engl J Med. 2019;380:2277.
    PubMed    


  87. VAN VOLLENHOVEN RF, Nurmohamed M
    Methotrexate for Prevention of Cardiovascular Events.
    N Engl J Med. 2019;380:2276-2277.
    PubMed    


    May 2019
  88. DE LA FUENTE J, Bird J
    Coronary Arteritis in IgG4-Related Disease.
    N Engl J Med. 2019;380:2156.
    PubMed    


  89. YU D, Blair JEA
    A STEMI Mimic.
    N Engl J Med. 2019;380:e41.
    PubMed    


  90. SCHWARTZ GG, Steg PG, Szarek M
    Alirocumab after Acute Coronary Syndrome. Reply.
    N Engl J Med. 2019;380:2077.
    PubMed    


  91. PIGNATELLI P, Camera M, Violi F
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    PubMed    


  92. ENNEZAT PV, Hansen MR
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    PubMed    


  93. LAN NSR, Yeap BB, Fegan PG
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075-2076.
    PubMed    


  94. ALKHALIL M
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075.
    PubMed    


  95. GAO Y, Hou B
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2074-2075.
    PubMed    


  96. THIELE H, Schneider S, Desch S
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock. Reply.
    N Engl J Med. 2019;380:1877.
    PubMed    


  97. YAN F, Thall P, Yuan Y
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2019;380:1876-1877.
    PubMed    


  98. WIVIOTT SD, Raz I, Sabatine MS
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2019;380:1881-1882.
    PubMed    


  99. AKINCI B
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1881.
    PubMed    


  100. BAGLIONI P
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1880-1881.
    PubMed    


    April 2019
  101. BHATT DL, Steg PG, Miller M
    Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.
    N Engl J Med. 2019;380:1678.
    PubMed    


  102. BORGHI C, Fogacci F, Cicero AFG
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1678.
    PubMed    


  103. CHAN LN
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1677.
    PubMed    


  104. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction. Reply.
    N Engl J Med. 2019;380.
    PubMed    


  105. FRANK RC, Hanidziar D
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380.
    PubMed    


    March 2019
  106. LANDONI G, Lomivorotov VV, Nigro Neto C, Monaco F, et al
    Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery.
    N Engl J Med. 2019 Mar 19. doi: 10.1056/NEJMoa1816476.
    PubMed     Abstract available


  107. LEMKES JS, Janssens GN, van der Hoeven NW, Jewbali LSD, et al
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMoa1816897.
    PubMed     Abstract available


  108. ABELLA BS, Gaieski DF
    Coronary Angiography after Cardiac Arrest - The Right Timing or the Right Patients?
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMe1901651.
    PubMed    


  109. LOPES RD, Heizer G, Aronson R, Vora AN, et al
    Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1817083.
    PubMed     Abstract available


  110. MEHTA SR
    Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMe1902214.
    PubMed    


  111. FERENCE BA, Ray KK, Catapano AL, Ference TB, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2019;380:1033-1042.
    PubMed     Abstract available


  112. OH J, Kang SM
    Rivaroxaban in Patients with Heart Failure.
    N Engl J Med. 2019;380:988.
    PubMed    


    February 2019
  113. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
    Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    N Engl J Med. 2019;380:752-762.
    PubMed     Abstract available


  114. FAUCHIER L, Clementy N, Bisson A
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:600.
    PubMed    


  115. STECKER EC, Walsh MN
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599.
    PubMed    



  116. Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599-601.
    PubMed    


    January 2019
  117. TAGGART DP, Benedetto U, Gerry S, Altman DG, et al
    Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.
    N Engl J Med. 2019;380:437-446.
    PubMed     Abstract available



  118. Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-300.
    PubMed    


  119. CHEUNG BMY
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299-300.
    PubMed    


  120. SANDHU AT, Maron DJ
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299.
    PubMed    


  121. BOGATY P, Brophy J
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-9.
    PubMed    


  122. KOROSOGLOU G, Giusca S
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298.
    PubMed    


  123. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380:171-176.
    PubMed    


  124. VERMA S, Mazer CD
    Open or Endoscopic Vein Harvesting for Coronary-Artery Bypass Grafting.
    N Engl J Med. 2019;380:189-191.
    PubMed    


    December 2018
  125. MATSUURA H, Ohya M
    Coronary-Artery Occlusion from Kawasaki's Disease.
    N Engl J Med. 2018;379:e42.
    PubMed    


  126. WADHERA RK, Bhatt DL
    Toward Precision Policy - The Case of Cardiovascular Care.
    N Engl J Med. 2018;379:2193-2195.
    PubMed    


    November 2018
  127. BURNETT JR, Hooper AJ
    PCSK9 - A Journey to Cardiovascular Outcomes.
    N Engl J Med. 2018;379:2161-2162.
    PubMed    


  128. KOPJAR T, Gasparovic H, Biocina B
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-7.
    PubMed    


  129. REHMAN SM, Duggan SMJ
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed    


  130. ALSAGHEIR A, Belley-Cote EP, Whitlock RP
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed    



  131. Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-1968.
    PubMed    


  132. ZENATI MA, Bhatt DL, Bakaeen FG, Stock EM, et al
    Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.
    N Engl J Med. 2018 Nov 11. doi: 10.1056/NEJMoa1812390.
    PubMed     Abstract available


  133. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1811403.
    PubMed     Abstract available


  134. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1809944.
    PubMed     Abstract available


  135. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812792.
    PubMed     Abstract available


  136. WIVIOTT SD, Raz I, Bonaca MP, Mosenzon O, et al
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812389.
    PubMed     Abstract available


  137. SCHWARTZ GG, Steg PG, Szarek M, Bhatt DL, et al
    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
    N Engl J Med. 2018 Nov 7. doi: 10.1056/NEJMoa1801174.
    PubMed     Abstract available


  138. ADRIAENSSENS T, Van de Werf F
    Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?
    N Engl J Med. 2018;379:1775-1776.
    PubMed    


  139. THIELE H, Akin I, Sandri M, de Waha-Thiele S, et al
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2018;379:1699-1710.
    PubMed     Abstract available


    October 2018

  140. Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582-1584.
    PubMed    


  141. MONTENEGRO MF, Lundberg JO, Weitzberg E
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583-4.
    PubMed    


  142. PEREZ-GOMEZ MV, Bartsch LA, Ortiz A
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583.
    PubMed    


  143. BHATTACHARYYA S, Macklin EA, Schwarzschild MA
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582.
    PubMed    


  144. DRAZEN JM
    Expression of Concern: Beltrami AP et al. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. N Engl J Med 2001;344:1750-7 and Quaini F et al. Chimerism of the Transplanted Heart. N Engl J Med 2002;346:5-15.
    N Engl J Med. 2018 Oct 17. doi: 10.1056/NEJMe1813801.
    PubMed    



  145. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    N Engl J Med. 2018;379:1486.
    PubMed    



  146. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-1389.
    PubMed    


  147. STEWART RAH
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1388.
    PubMed    


  148. JENKINS D, Sievenpiper J, Jones P
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-8.
    PubMed    


  149. CORREIA LCL
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387.
    PubMed    


    September 2018
  150. FIELD ME, Page RL
    Another Shock for Sudden Death Prevention after Myocardial Infarction.
    N Engl J Med. 2018;379:1274-1275.
    PubMed    


  151. OLGIN JE, Pletcher MJ, Vittinghoff E, Wranicz J, et al
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2018;379:1205-1215.
    PubMed     Abstract available


  152. MCNEIL JJ, Wolfe R, Woods RL, Tonkin AM, et al
    Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    N Engl J Med. 2018 Sep 16. doi: 10.1056/NEJMoa1805819.
    PubMed     Abstract available


    August 2018
  153. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Abstract available


  154. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Abstract available


  155. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    PubMed     Abstract available



  156. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMoa1805971.
    PubMed     Abstract available


  157. HOFFMANN U, Udelson JE
    Imaging Coronary Anatomy and Reducing Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMe1809203.
    PubMed    


  158. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Abstract available


  159. WEINER RB, Hucker WJ, Meyersohn NM, Dudzinski DM, et al
    Case 25-2018: A 63-Year-Old Man with Syncope.
    N Engl J Med. 2018;379:670-680.
    PubMed    


    July 2018
  160. XAPLANTERIS P, Fournier S, Pijls NHJ, Fearon WF, et al
    Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    N Engl J Med. 2018;379:250-259.
    PubMed     Abstract available


    June 2018
  161. CUERVO G, Viasus D, Carratala J
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2540.
    PubMed    


  162. BUCKLEY LF
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539-40.
    PubMed    


  163. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Ortiz A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed    


  164. WIESSMAN M, Shlomai A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed    


  165. WAXMAN DA, Kanzaria HK, Schriger DL
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-9.
    PubMed    



  166. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-2541.
    PubMed    


  167. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
    PubMed    


  168. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
    PubMed     Abstract available


  169. ARBOINE L, Palacios JM
    Left Main Coronary Artery Aneurysm.
    N Engl J Med. 2018;378:e32.
    PubMed    


    May 2018
  170. SHAPIRA OM
    Radial Artery as the Preferred Second Conduit for Coronary Bypass.
    N Engl J Med. 2018;378:2134-2135.
    PubMed    


  171. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    PubMed     Abstract available


    April 2018
  172. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
    Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
    PubMed     Abstract available


  173. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    PubMed     Abstract available


  174. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    PubMed    


  175. ZHAO YT, Huang YS
    ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
    N Engl J Med. 2018;378:e22.
    PubMed    


  176. AMELOOT K, Daemen J, Van Mieghem N
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360-1.
    PubMed    


  177. PAPPALARDO F, Bertoldi L
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360.
    PubMed    


  178. PASCERI V, Pelliccia F, Speciale G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359-60.
    PubMed    


  179. FERREIRA RM, Salis LHA, e Silva NAS
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359.
    PubMed    


  180. FLEISSNER F, Haverich A, Warnecke G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-9.
    PubMed    


  181. SHARMA S, Lardizabal J
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358.
    PubMed    



  182. PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-1361.
    PubMed    


    March 2018
  183. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
    Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
    N Engl J Med. 2018;378:1043-1053.
    PubMed    


  184. WHITE WB, Saag KG, Becker MA, Borer JS, et al
    Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
    PubMed     Abstract available


  185. LEE F, Maggiore P, Chung K
    Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
    N Engl J Med. 2018;378:960-962.
    PubMed    


    February 2018

  186. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2018;378:782.
    PubMed    


    January 2018
  187. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed    


  188. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:345-353.
    PubMed     Abstract available


  189. CAHILL TJ, Wijesurendra RS, Casadei B
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed    


  190. HELFT G, Le Feuvre C, Zaman A
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed    


  191. JEONG YH, Bae JS, Gurbel PA
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:396.
    PubMed    


  192. AJANI AE
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-6.
    PubMed    



  193. Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-398.
    PubMed    


  194. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed    


  195. WEBSTER MWI, Stables RH
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed    


  196. SHAH R
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed    


  197. VIJ A, Kodumuri V
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed    


  198. BULLUCK H
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed    



  199. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298-301.
    PubMed    


  200. STONE GW
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:300-1.
    PubMed    



  201. Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-202.
    PubMed    


  202. LELLOUCHE F, Simon M, L'Her E
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:201.
    PubMed    


  203. SAMADANI U, Affana CK
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-1.
    PubMed    


  204. ROSENBAUM L
    Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
    N Engl J Med. 2018;378:101-103.
    PubMed    


    December 2017
  205. IMPRIALOS KP, Stavropoulos K, Doumas M
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed    


  206. HOLMAN RR, Bethel MA, Hernandez AF
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed    


  207. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
    Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
    N Engl J Med. 2017;377:2475-2484.
    PubMed    


  208. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed    


    November 2017

  209. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-2099.
    PubMed    


  210. RAJAGOPALAN S, Brook R
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098-9.
    PubMed    


  211. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098.
    PubMed    


  212. BAGLIONI P
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-8.
    PubMed    


  213. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed    


  214. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    PubMed     Abstract available


  215. JACOB KA, Gianoli M, van Dijk D
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897-8.
    PubMed    


  216. TAGGART DP, Puskas JD
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897.
    PubMed    


  217. JONES SG, Pullan MD, Kirmani BH
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1896-7.
    PubMed    


  218. NOZAWA T, Imagawa T, Ito S
    Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
    N Engl J Med. 2017;377:1894-1896.
    PubMed    



  219. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1898-1899.
    PubMed    


    October 2017
  220. THIELE H, Akin I, Sandri M, Fuernau G, et al
    PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
    PubMed     Abstract available


  221. MONTONE RA, Minelli S
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595-6.
    PubMed    


  222. AGGARWAL S, Pavlides G
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595.
    PubMed    


  223. BHATT DL
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1598-1599.
    PubMed    


  224. DAVIES JE, Sen S, Escaned J
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1597-1598.
    PubMed    


  225. PIJLS NHJ, De Bruyne B
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596.
    PubMed    



  226. Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596-7.
    PubMed    


    September 2017
  227. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
    N Engl J Med. 2017;377:1217-1227.
    PubMed     Abstract available


  228. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    PubMed     Abstract available


  229. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: